Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,619,084
  • Shares Outstanding, K 104,775
  • Annual Sales, $ 482,380 K
  • Annual Income, $ 106,140 K
  • EBIT $ 143 M
  • EBITDA $ 137 M
  • 60-Month Beta 0.51
  • Price/Sales 11.33
  • Price/Cash Flow 54.47
  • Price/Book 8.56

Options Overview Details

View History
  • Implied Volatility 67.64% ( +3.42%)
  • Historical Volatility 41.97%
  • IV Percentile 40%
  • IV Rank 37.63%
  • IV High 156.92% on 05/17/24
  • IV Low 13.78% on 08/16/24
  • Put/Call Vol Ratio 0.28
  • Today's Volume 516
  • Volume Avg (30-Day) 843
  • Put/Call OI Ratio 1.26
  • Today's Open Interest 29,303
  • Open Int (30-Day) 34,722

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.37
  • Number of Estimates 4
  • High Estimate 0.44
  • Low Estimate 0.28
  • Prior Year 0.28
  • Growth Rate Est. (year over year) +32.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.51 +5.54%
on 12/23/24
62.22 -16.02%
on 12/04/24
-6.34 (-10.83%)
since 11/27/24
3-Month
42.01 +24.39%
on 10/31/24
62.22 -16.02%
on 12/04/24
+8.33 (+18.95%)
since 09/27/24
52-Week
20.84 +150.74%
on 04/22/24
62.22 -16.02%
on 12/04/24
+19.44 (+59.22%)
since 12/27/23

Most Recent Stories

More News
Insider Sale: Director at $CORT (CORT) Sells 2,200 Shares

Daniel N JR Swisher, a director at $CORT ($CORT), sold 2,200 shares of the company on 12-10-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their...

CORT : 52.27 (-2.54%)
Stocks Settle Lower as Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.53%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.68%. Stock indexes...

AMAT : 165.25 (-1.37%)
CVS : 44.39 (-1.18%)
AVGO : 239.80 (-2.27%)
$IUXX : 21,313.78 (-2.09%)
UNH : 508.63 (-0.49%)
ZNH25 : 108-160 (-0.14%)
QCOM : 156.10 (-1.53%)
JAZZ : 123.97 (-1.47%)
KDP : 32.12 (-0.59%)
LRCX : 72.78 (-1.64%)
WBD : 10.60 (-0.19%)
$DOWI : 42,820.16 (-1.17%)
CORT's Dazucorilant Fails to Meet Goal in Neurologic Disorder Study

Corcept Therapeutics Incorporated CORT announced data from the phase II DAZALS study evaluating its selective cortisol modulator, dazucorilant, for treating patients with amyotrophic lateral sclerosis...

CORT : 52.27 (-2.54%)
IMCR : 29.60 (-2.05%)
CSTL : 26.66 (-1.62%)
SPRO : 1.0334 (+9.48%)
Stocks Pressured by Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down -0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.41%. Stock indexes today are posting...

AMAT : 165.25 (-1.37%)
AVGO : 239.80 (-2.27%)
$IUXX : 21,313.78 (-2.09%)
ZNH25 : 108-160 (-0.14%)
QCOM : 156.10 (-1.53%)
JAZZ : 123.97 (-1.47%)
EFX : 254.86 (-1.52%)
KDP : 32.12 (-0.59%)
LRCX : 72.78 (-1.64%)
WBD : 10.60 (-0.19%)
$DOWI : 42,820.16 (-1.17%)
CACI : 402.07 (-1.46%)
Stocks Weaken on Stagflation Concerns

The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.58%. Stock indexes today are mildly...

AMAT : 165.25 (-1.37%)
AVGO : 239.80 (-2.27%)
$IUXX : 21,313.78 (-2.09%)
ZNH25 : 108-160 (-0.14%)
QCOM : 156.10 (-1.53%)
JAZZ : 123.97 (-1.47%)
EFX : 254.86 (-1.52%)
KDP : 32.12 (-0.59%)
LRCX : 72.78 (-1.64%)
WBD : 10.60 (-0.19%)
$DOWI : 42,820.16 (-1.17%)
CACI : 402.07 (-1.46%)
Insider Sale: See Remarks of $CORT (CORT) Sells 1,411 Shares

Joseph Douglas Lyon, the See Remarks of $CORT ($CORT), sold 1,411 shares of the company on 11-22-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 14.2% of...

CORT : 52.27 (-2.54%)
Corcept Shares Rise More Than 60% in Three Months: Here's Why

Shares of Corcept Therapeutics Incorporated CORT have rallied 60.7% in the past three months against the industry’s decline of 9.9%.The company’s sole-marketed drug, Korlym (mifepristone), which is...

CORT : 52.27 (-2.54%)
IMCR : 29.60 (-2.05%)
CSTL : 26.66 (-1.62%)
SPRO : 1.0334 (+9.48%)
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance

For Immediate ReleaseChicago, IL – November 11, 2024 – Today, Zacks Equity Research like Madrigal Pharmaceuticals MDGL, Corcept Therapeutics CORT, Catalyst Pharmaceuticals CPRX, Larimar Therapeutics...

CORT : 52.27 (-2.54%)
TBPH : 9.57 (-2.94%)
MDGL : 314.24 (+0.06%)
LRMR : 3.91 (-2.01%)
CPRX : 21.26 (-2.97%)
5 Small Drug Stocks to Buy as Trump Gets Re-Elected

The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic Inflation Reduction Act (“IRA”). With Donald Trump’s reelection, the biotech...

CORT : 52.27 (-2.54%)
TBPH : 9.57 (-2.94%)
MDGL : 314.24 (+0.06%)
LRMR : 3.91 (-2.01%)
CPRX : 21.26 (-2.97%)
5 Stocks With Recent Price Strength to Tap Wall Street Rally

U.S. stock markets started November, adding more steam to the ongoing rally. The primary reason was the anticipation of Donald Trump becoming the 47th president of the country. On Nov 5, Trump clinched...

CORT : 52.27 (-2.54%)
SEZL : 259.04 (-4.87%)
CDXC : 5.45 (-2.85%)
TILE : 24.81 (-2.44%)
BGC : 9.01 (-1.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone),...

See More

Key Turning Points

3rd Resistance Point 56.22
2nd Resistance Point 54.95
1st Resistance Point 54.29
Last Price 52.27
1st Support Level 52.35
2nd Support Level 51.08
3rd Support Level 50.42

See More

52-Week High 62.22
Last Price 52.27
Fibonacci 61.8% 46.41
Fibonacci 50% 41.53
Fibonacci 38.2% 36.65
52-Week Low 20.84

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar